NYR 26.4% 11.0¢ nyrada inc.

Ann: Brain Injury Program GLP Studies Further Update, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 211 Posts.
    lightbulb Created with Sketch. 22
    Mate what are smoking

    Do you even read what you write. Who’s is Roch your Ex lol

    GLP looks at safety amongst varied animal species so what they dose a human in phase 1 isn’t cytotoxic and what safety results they got before in preclinical studies match up properly and is done by an independent organisation to make sure it’s truthfully done. It’s why they tested in specific human genomes, invitro and invivo.

    Phase 1 needs ethical clearance which takes 3 weeks after GLP results all come out in the next few weeks and they can start phase 1 dosing hence why it’s next quarter phase 1 starts and it’s fully funded but listen into the webinar next week.

    Mate you’re embarrassing your self 2 years to start phase 1, don’t have any cash lol, delisting, don’t even understand that AGN has already proven the mechanism of action of NYR, don’t even understand what a GLP is. You don’t even know what day it is because you MSB posts make me laugh “Guys up 2 cents today, down 2 cents today, company going to $10 dollars a 30 billion dollar market cap lol on FDA approval lol”. Please looking at your other investments like LDX calling 30 cents on a COVID test and now the share price is less than when you were posting. Dont lie and people will listen to your post. Unfortunately your a troll
    Last edited by Bendunstan: 10/08/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.